Immunocore Holdings IMCR
NASDAQ IMCR
$30.85 +0.21 (+0.69%)
At close: Sep 29, 2026 · 4:00 PM EDT

Immunocore Holdings (IMCR) Total Current Liabilities (2019 - 2026)

Updated

Immunocore Holdings (IMCR) posted Total Current Liabilities of $235.2 million for Q2 2026, up 38.3% from $170.08 million a year earlier but down 2.0% from the prior quarter.

Analysis

Immunocore Holdings (IMCR) Total Current Liabilities (2019 - 2026) Analysis & Trends

At the end of FY2025, Immunocore Holdings' Total Current Liabilities came in at $246.7 million, up 16.3% from FY2024.

  • Annual Total Current Liabilities has increased for five consecutive years, with a five-year compound annual growth rate of 27.7% (FY2020 to FY2025).
  • In prior years, Immunocore Holdings' Total Current Liabilities was $212.18 million in FY2024 (+52.6%), $139.02 million in FY2023 (+37.9%), $100.84 million in FY2022 (+19.8%) and $84.18 million in FY2021 (+15.9%).
  • Quarterly Total Current Liabilities has run from a low of $82.47 million in Q4 2021 to a high of $266.25 million in Q3 2024 over five years.
  • On a year-over-year basis, Total Current Liabilities has increased in each of the last three quarters, with growth averaging 17.2% over the last seven quarters.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q1 2026, with growth of 61.0%; the weakest was Q3 2025, with a decline of 36.0%.
  • According to Business Quant data, Total Current Liabilities for the three prior quarters was $240.11 million (Q1 2026), $246.7 million (Q4 2025) and $170.35 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Immunocore Holdings 1.58 Bn -1.90 Bn 114.84 Mn 235.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 235.20 Mn
Mar 31, 2026 240.11 Mn
Dec 31, 2025 246.70 Mn
Sep 30, 2025 170.35 Mn
Jun 30, 2025 170.08 Mn
Mar 31, 2025 149.16 Mn
Dec 31, 2024 212.18 Mn
Sep 30, 2024 266.25 Mn
Jun 30, 2024 185.10 Mn
Mar 31, 2024 155.29 Mn
Dec 31, 2023 139.02 Mn
Jun 30, 2023 115.48 Mn
Dec 31, 2022 97.46 Mn
Sep 30, 2022 91.01 Mn
Dec 31, 2021 82.47 Mn
Dec 31, 2020 72.62 Mn
Dec 31, 2019 108.66 Mn
API Access

Immunocore Holdings Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=IMCR&period=max&api_key=YOUR_API_KEY